Advertisement
Nektar Therapeutics (NKTR)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Follow
At close: 04:00PM EST
After hours:
| Previous Close | 1.0100 |
| Open | 1.0300 |
| Bid | 1.0200 x 600 |
| Ask | 1.0700 x 300 |
| Day's Range | 1.0100 - 1.1100 |
| 52 Week Range | 0.4200 - 1.9300 |
| Volume | |
| Avg. Volume | 1,365,967 |
| Market Cap | 193.681M |
| Beta (5Y Monthly) | 0.61 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.8400 |
| Earnings Date | Nov 07, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 4.10 |
PR NewswireNektar Therapeutics Presents First Preclinical Data from Novel CSF-1 Program, NKTR-422, at 2024 American College of Rheumatology (ACR) Convergence
Nektar Therapeutics (Nasdaq: NKTR) today announced its oral presentation highlighting preclinical data on NKTR-422 at the 2024 American College of Rheumatology (ACR) conference, being held in Washington, D.C. from November 14-19, 2024.
Simply Wall St.Nektar Therapeutics (NASDAQ:NKTR) Just Reported And Analysts Have Been Lifting Their Price Targets
Nektar Therapeutics ( NASDAQ:NKTR ) investors will be delighted, with the company turning in some strong numbers with...
Advertisement
Advertisement
Advertisement
© 2024 Yahoo. All rights reserved.